Allergology: Advanced Therapeutics in Allergology — Treatise on Medicine and Precision Medicine

Allergology and Immunology · Clinical Specialties

How it begins

Un análisis exhaustivo del sistema inmunitario patológico: desde la inducción molecular de tolerancia periférica hasta el bloqueo ultraespecífico de citocinas alarmantes, inmunoterapia de nueva generación y medicina de precisión genómica.

What it covers

1. Precision Medicine Treaty
2. Subcutaneous and Sublingual Allergen Immunotherapy (ITA)
3. · Detailed Biochemical and Immunological Mechanisms
4. · Administration Guidelines and Security Protocols
5. Biologicals in Allergic Diseases: Monoclonal Antibodies (mAbs)
6. · Comparison of Key Clinical Trials and Reduction of Exacerbation Rates
7. Drug Desensitization (DAP)
8. · Boston Standard 12 Step Protocol (Castells et al.)
9. Advanced Therapeutics in Atopic Dermatitis
10. · Oral Janus Kinase Inhibitors (iJAK)
11. Chronic Spontaneous Urticaria (CSU)
12. · Therapeutic Escalation Algorithm EAACI/GA²LEN/EDF/WAO
13. Advanced Management of Severe Uncontrolled Asthma
14. · Biological Decision Algorithm in Severe Asthma T2-High
15. · Bronchial Thermoplasty (Non-Pharmacological Therapeutics)
16. Eosinophilic Esophagitis (EoE)
17. · Pillars of Pharmacological Medical Treatment
18. · Elimination Dietary Schemes
19. Oral Immunotherapy (OIT) in Food Allergy
20. · Peanut Desensitization Protocol using AR101 (Palforzia®)
21. · Addition of Omalizumab as a Facilitator of OIT (Combination Therapy)
22. Hereditary Angioedema (HAE)
23. · The Cascade of the Contact System and Bradykinin Induction
24. · Advanced Pharmacological Treatments
25. Hypersensitivity Reactions to Chemotherapy and Targeted Therapies
26. Severe and Refractory Anaphylaxis: Pathophysiology and Critical Support
27. · Management of Refractory Anaphylactic Shock in Beta-Blocked Patients
28. · Third Line Strategies in Advanced Life Support
29. Recombinant Allergen Vaccines and New Platforms
30. · Design of Hypogenic Recombinant Allergens (Recombinant Allergoids)
31. · New Adjuvant Platforms: CpG and MPLA Reasons
32. Biomarkers in Biological and Immunotolerance Therapies
33. Pharmacogenomics and Precision Medicine in Allergy
34. · Key Receptor Polymorphisms in Asthma and AD
35. · High Resolution HLA Associations in Serious Pharmacodermias
36. · Epigenetic Modifications During AIT